Appeal of Dismissal of Whistleblower Case Against Johnson & Johnson, DePuy Rejected by Appeals Court - Marketscreener.com

by MarketScreener

Fri, Jun 2, 2023 09:04 ET

in Employment News, Press Release

MT Newswires 2023

Analyst Recommendations on JOHNSON & JOHNSON

05/30	Kenvue Initiated at Outperform by RBC, Price Target Set at $29 as Firm Highlights Johns..	MT
04/20	UBS Adjusts Johnson & Johnson Price Target to $177 From $164, Maintains Neutral Rating	MT
04/19	Atlantic Equities Trims Price Target on Johnson & Johnson to $167 From $168, Keeps Neut..	MT

More recommendations

Duration : Auto.

Read Full Story: https://news.google.com/rss/articles/CBMisAFodHRwczovL3d3dy5tYXJrZXRzY3JlZW5l...

False Claims

Access DX to pay $36.4 Million to resolve Allegations - WNEG Radio

by Chad Dorsett

2 hours ago

Access DX Laboratory (“Access DX”), its former CEO Michael Stewart, and Florida businessman Harold Shatz will pay a combined total of $36.4 million to resolve allegations that they violated the Fa...

PA DISPUTES DHS CLAIMS OF OVER 14K NON-CITIZEN REGISTERED VOTERS - WCCS AM1160 & 101.1FM

5 hours ago

Health Care Fraud Roundup: July 11–July 24, 2026 - paragoninstitute.org

7 hours ago

Medicaid fraud task force ‘a sham,’ former state directors charge - thegazette.com